In this role Terrie has responsibility for the US, Canada and Latin America.

Prior to joining Celgene, Terrie was Merck’s Senior Vice President and GM of the Global Women’s Health franchise from 2009-2013. She had commercial responsibility for $3 Billion business, spanning the categories of contraception, fertility, HRT and osteoporosis. The UNFPA honored Terrie with an award for the Health and Dignity of Women and Girls in 2012.

Terrie previously served as General Manager for Schering-Plough in Switzerland and Australia.

Terrie also served in a variety of sales, marketing and management roles at the former Pharmacia, including New Zealand Country President, Sales and Marketing Director and Group Product Manager. She has worked across many therapeutic categories including Immunology, Gastroenterology, Oncology, Ophthalmology, Metabolic, Pain and Women’s Health.

Terrie earned her Bachelor of Science and Graduate Diploma of Marketing degrees from the University of Technology in Sydney, Australia.

In April of 2014, Terrie was appointed to the Board of Directors of H. Lundbeck A/S.